American depositary shares of GSK jumped more than 8% Wednesday after the drugmaker reported better-than-expected quarterly results and boosted its long-term sales forecast. Sales of vaccines against ...

Listen to this article The Tysons tech company formerly known as MicroStrategy has a new moniker: Strategy. In addition to announcing a new name, the Bitcoin behemoth chaired by Michael Saylor ...

GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 ...

MicroStrategy, the business intelligence firm and Bitcoin treasury company co-founded by Michael Saylor has rebranded to ...

European stocks closed mostly higher on Wednesday with investors shrugging off concerns about tariffs for now and focusing on ...

MicroStrategy Inc. (NASDAQ:MSTR) has officially rebranded as Strategy, reflecting its sharpened focus on Bitcoin ...

Annual core operating profit increased in 2024 for British pharmaceutical company GSK compared to 2023, the company reported ...

The pharmaceutical company said promising pipeline developments and high demand for drugs in its specialty segment lifted ...

European shares were slightly lower on Wednesday as tech stocks declined, offsetting gains in the healthcare and financial sectors.

DelveInsight's Peptide-drug Conjugate Market Insights report provides the current and forecast market analysis, individual ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and Goliath dynamic” in 2024, report says.

That agreement came amid a wave of smaller deals from GSK, Eli Lilly and lesser known ... Additionally, large megafunds, health-systems and tech companies held an outsized amount of influence ...